4.4 Article

Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Rheumatoid Arthritis-Interstitial Lung Disease-associated Mortality

Amy L. Olson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Public, Environmental & Occupational Health

Toward improved statistical methods for analyzing Cotinine-Biomarker health association data

Tulay Koru-Sengul et al.

Tobacco Induced Diseases (2011)

Article Rheumatology

Anti-TNF-alpha Agents Are Less Effective for the Treatment of Rheumatoid Arthritis in Current Smokers

A. Abhishek et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2010)

Article Medicine, General & Internal

Progressive preclinical interstitial lung disease in rheumatoid arthritis

Bernadette R. Gochuico et al.

ARCHIVES OF INTERNAL MEDICINE (2008)

Article Medicine, General & Internal

Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women

Karen H. Costenbader et al.

AMERICAN JOURNAL OF MEDICINE (2006)

Article Rheumatology

Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis

BM Nyhäll-Wåhlin et al.

ANNALS OF THE RHEUMATIC DISEASES (2006)

Article Rheumatology

A new model for an etiology of rheumatoid arthritis

L Klareskog et al.

ARTHRITIS AND RHEUMATISM (2006)

Article Rheumatology

Predictors of infection in rheumatoid arthritis

MF Doran et al.

ARTHRITIS AND RHEUMATISM (2002)